We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

By LabMedica International staff writers
Posted on 01 Nov 2024

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. More...

Early in the disease, patients experience hematuria, which is followed by proteinuria and, eventually, end-stage renal failure that necessitates renal replacement therapies such as dialysis or kidney transplantation. The exact prevalence of Alport syndrome remains uncertain; however, the X-linked form, caused by a mutation in a gene located on the X chromosome, is the most prevalent type. Males, who possess a single X chromosome (XY), tend to experience more severe symptoms compared to females, who have two X chromosomes (XX). Although female patients with X-linked Alport syndrome are often thought to have a milder variant of the disease, studies conducted in the United States and Japan indicate that about 15% of these women may reach end-stage renal failure by age 40. Diagnosing Alport syndrome typically involves genetic testing and a pathological examination of kidney tissue. However, accurately predicting renal outcomes in female patients presents challenges, underscoring the need for indicators that can evaluate the effectiveness of renal protective treatments, such as antihypertensive medications, which have shown potential to improve patient prognosis.

A research team at the University of Tsukuba (Tsukuba, Japan) has developed an innovative imaging technique to visualize lesions in the glomerular basement membrane using a mouse model of Alport syndrome. By applying deep learning methodologies to pathological image data, the researchers achieved automated detection of lesions through artificial intelligence (AI). The study utilized a mouse model that simulates Alport syndrome to compare the kidney lesions between male and female subjects, aiming to provide insights into the specifics of these lesions in females. They created a modified periodic acid methenamine silver stain to observe basement membrane lesions in areas where type IV collagen α5 is intact as well as in regions where it is absent, which are distinctive in female patients.

Additionally, the AI system was able to automatically identify these lesions using deep learning techniques, as detailed in research published in the American Journal of Pathology. The quantitative measurements of kidney lesions in female mice, as assessed by the imaging AI software, showed a positive correlation with proteinuria levels, suggesting that this approach may assist in predicting kidney function outcomes in women with Alport syndrome.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.